Covid-19
-
Moderna and Pfizer grapple with market challenges and future prospects
USA — Moderna, the renowned biotech firm responsible for the COVID-19 vaccine, recently experienced a significant decline in its market value, losing a staggering US$6.8…
-
Urgent response as new long Covid stats prompt US$45 million initiative in the US
USA — In a recent study, shocking statistics have come to light, revealing that the specter of long Covid continues to haunt the United States,…
-
Health experts raise alarm as long COVID-19 takes hold in Uganda
UGANDA — In a world still grappling with the enduring aftermath of the COVID-19 pandemic, the Makerere University Lung Institute’s experts are sounding the alarm…
-
WHO warns of alarming COVID-19 trends ahead of northern hemisphere winter
SWITZERLAND —In a sobering update, World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus has highlighted “concerning trends for COVID-19 ahead of the winter season…
-
Two cases of the new coronavirus strain EG.5 detected in Egypt: MoH
EGYPT – Egypt’s Ministry of Health and Population (MOHP) has deployed the national surveillance system following the confirmation of two cases of the new coronavirus…
-
The Saudi Ministry of Health intensifies efforts to maintain coronavirus-free status
SAUDI ARABIA – The Saudi Ministry of Health is intensifying testing and tracing efforts to prevent the new coronavirus variant EG.5, also known as Eris,…
-
WHO urges vigilance as COVID-19 cases show resurgence in Europe and the US
SWITZERLAND — Amid a gradual resurgence of COVID-19 cases, including hospitalizations, in select European nations, Dr. Hans Kluge, the World Health Organization’s (WHO) regional director…
-
WHO classifies EG.5 Coronavirus variant as “Variant of Interest”
SWITZERLAND — In a critical move, the World Health Organization (WHO) has designated the EG.5 coronavirus strain circulating in the United States and China as…
-
Moderna looks to rise beyond a 94% COVID-19 vaccine revenue decline, banking on boosters to transform its path forward
USA — The trajectory of Moderna, once heralded for its COVID-19 vaccine triumph, has encountered a significant pivot as the company grapples with a substantial…
-
US government loses nearly US$200 billion in COVID-19 relief programs, Inspector General report reveals
USA — The US Small Business Administration (SBA), a federal watchdog, has disclosed that the US Government suffered substantial losses of nearly US$200 billion due…